Microbicides May Just Be Another Anti-HIV Tool
By Margaret Mangani (The Times of Zambia-Ndola) 2 December 2008: ANALYSIS
http://allafrica.com/stories/200812020511.html
As the world celebrates the World AIDS Day which fell yesterday,
December 1, it is important to recall that the pandemic broke out 20
years ago and a lot of efforts and finances have gone into research
studies for a cure which has culminated into interventions to prevent
new infections from occurring.
Although global figures still remain high coupled with a gloomy picture
of many lives that have so far been claimed especially in the most
productive group, it is delighting to note that Zambia has in the past
few years recorded a decline in prevalence rates from 16 per cent to
14.3 per cent.
The Government in committing itself to the fight against the pandemic
states that more funds will be pumped into the exercise to halt the
pandemic.
Hence, the on-going sensitisation programmes which are targeting mostly
the vulnerable people in society.
In addition, prevention messages have continued to be resounded at most
fora with the aim of reducing the scourge in conjunction with other
interventions while people are being urged to seek Voluntary
Counselling and Testing (VCT) services for them to know their
status.
It is common to note that condom use is one such intervention that has
been developed although it has come under heavy criticism from some
quarters for being in conflict with some religious beliefs.
The pandemic affects everyone regardless of sex, creed and status and
so if one is not infected, they are affected in a way and it is for
this reason that the condom was developed to act a barrier against HIV
and not that it should promote promiscuity.
But from the information availed by scientists, it puts women more at a
greater risk of the infection because of their biological make-up as
well as lack of control over their sexuality.
Women lack the power to negotiate for safer sex with either their
spouses or partners and this puts them at even a greater risk of
infection than their male counterparts.
There is also another transmission mode through mother-to-child
transmission wich can affect the unborn child.
There are also issues of poverty. Women who lack economic empowerment
find themselves engaging in unsafe sex as a means of earning an income
or obtaining favours from their male counterparts for either a
promotion or a job, thus endangering their lives.
At the same time, some girls have been victims of defilement and
violent rape that puts them in a precarious situation of contracting
HIV.
It is for this reason that research is being done in an effort to
empower the woman with a tool that would protect her from being
infected by HIV.
Interventions such as the female condom, abstinence and faithfulness
are already being practised by activists side-by-side in an effort to
reduce the scourge, but still, the statistics of infections are high,
especially in the sub-Saharan region coupled with increased poverty
levels.
Stakeholders argue that the battle against the pandemic cannot be
fought in isolation but requires a multi-sectoral approach to combat
it.
AIDS activist and medical practitioner, Mannaseh Phiri, cites multiple
concurrent partners, alcohol and substance use and bad cultural
practices as some of the drivers of the HIV pandemic in Africa.
While this is true, another initiative is still being developed in the
form of Microbicide gels.
Microbicides are agents that can prevent the transmission of HIV and
other sexually transmitted diseases when applied in the vagina or
rectum.
The successful development of the gels would provide a critical adjunct
to male and female condoms as well as a needed complement to existing
efforts to develop a therapeutic or prophylactic HIV vaccine.
The Centre for Infectious Diseases Research in Zambia (CIDRZ) has been
conducting a randomised clinical trial on two different microbicide
gels at the Kamwala study clinic in Lusaka for two-and-a-half
years.
This HIV prevention research study is aimed at seeing if a microbicide
gel is effective in preventing HIV infection in women.
Similar studies have been carried out simultaneously in South Africa,
Malawi, Zimbabwe and the United States of America as part of the HIV
prevention trials.
In Kamwala, this study called the Well Woman and Partner Study,
occurred over the last two-and-a-half years.
According to principal investigator of the Kamwala site, Muzala
Kapinga, the gels have been proved to be safe for use and do not cause
any adverse effects on those participating in the study.
The gels being used are Buffer gel, which maintains acidity of the
vagina, and 0.5 per cent PRO 2000 gel P that prevents viral entry into
CD 4 cells.
Dr Kaping'a was, however, quick to point out that although the study
had reached an advanced stage, as the safety, a report would have to be
compiled early next year to ascertain the gels' efficacy.
"Gels are safe for use by women but the question of their effectiveness
as to whether they can prevent HIV is what remains to be answered.
Results will be early next year," she said.
Dr Kaping'a revealed this recently in Lusaka at the University Teaching
Hospital (UTH) during a media briefing to create awareness on the
ongoing research.
Dr Kaping'a said the study population involved a total of 3,100 HIV
uninfected women with 320 coming from Lusaka, aged between 18 and 30
years old.
In one of the documentaries shown to the participants to illustrate the
impact of the pandemic on women and the need to develop a safer
intervention method other than the already existing ones, former United
Nations (UN) special envoy for AIDS Stephen Lewis was quoted as saying
that if the barrier on HIV/AIDS prevention could not be broken through
behavioural change, then the best thing to do was to empower women with
microbicide gels.
"Unless we confront it in a fashion that is uncompromising, we are
going to lose more women. That is why microbicides are important," he
said.
And Clementine Mumba, representing Treatment, Advocacy and Literacy
Campaign (TALC), said the research into microbicides was a good
initiative, particularly designed for women for the following
reasons:
-That most women are not in a position to negotiate for safer sex with
either their spouses or partners as they lack asertiveness
-Microbicides will help most married women who are currently in the
high risk group of infection to protect themselves against infections,
and
-Female condoms are readily available in Zambia but only a few women
can afford them as they are costly while those who have used them
before complain of discomfort and noise during sexual
intercourse.
Ms Mumba said, however, that caution must be exercised to ensure that
only the best interventions were brought into the country for use by
the local people.
She made this suggestion in the wake of the pharmaceutical regulatory
authority's lack of equipment to ensure transparency and
non-coerciveness.
It is believed that once proved effective, the gels should be made
readily available and affordable to all ordinary citizens as an
effective method of empowering women against the HIV pandemic than
having to look for expensive female condoms which are rare to find.

